Wegener Granulomatosis: Clinical Trials

12 trials for Wegener Granulomatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 unknown, 1 active not recruiting, 1 terminated. 3 Phase 3, 2 Phase 4, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Unknown 1
Phase 42Terminated 1, Unknown 1
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Wegener Granulomatosis: new trials by email Literature Review of Wegener Granulomatosis trials Research Report on Wegener Granulomatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hydroxychloroquine in ANCA Vasculitis Evaluation
Hydroxychloroquine, Placebo - ANCA Associated Vasculitis, Microscopic Polyangiitis
Phase 4TerminatedGuy's and St Thomas' NHS Foundation Trust432020-12-172026-04-29
TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Trimethoprim Sulfamethoxazole - Granulomatosis With Polyangiitis, Wegener Granulomatosis
Phase 1 / Phase 2Active not recruitingUniversity of Pennsylvania82019-03-272026-09-25
Journey of Patients With Vasculitis From First Symptom to Diagnosis
Online Questionnaire - Vasculitis, Systemic Vasculitis
CompletedUniversity of Pennsylvania4562018-01-112018-06-06
Impact of Vasculitis on Employment and Income
online questionnaire - Vasculitis, Systemic Vasculitis
CompletedUniversity of South Florida4262015-06-012016-01-28
Low-dose Glucocorticoid Vasculitis Induction Study
Rituximab, Glucocorticoids - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis
Phase 4UnknownChiba University1402014-10-012021-01-27
VCRC Patient Contact Registry Patient-Reported Data Validation Study
Behcet's Disease, Churg-Strauss Syndrome
CompletedUniversity of South Florida1982014-05-012019-10-16
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
5 mg prednisone, 0 mg prednisone - Granulomatosis With Polyangiitis, Wegener Granulomatosis
Phase 3UnknownUniversity of South Florida122014-02-172024-07-29
Rituximab Vasculitis Maintenance Study
Rituximab, Azathioprine - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis
Phase 3CompletedCambridge University Hospitals NHS Foundation Trust1882013-04-012022-03-18
PRO Development for ANCA Associated Vasculitis
Wegener Granulomatosis, Microscopic Polyangiitis
UnknownUniversity of Oxford502012-09-012015-05-28
Educational Needs of Patients With Systemic Vasculitis
Behcet's Disease, Churg-Strauss Syndrome
CompletedUniversity of South Florida3862012-03-012014-07-15
Vasculitis Illness Perception (VIP) Study
Wegener Granulomatosis, Microscopic Polyangiitis
CompletedUniversity of South Florida7072011-10-012014-07-15
Efficacy Study of Two Treatments in the Remission of Vasculitis
Rituximab, Azathioprine - Wegener Granulomatosis, Microscopic Polyangiitis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1172008-10-012025-11-20

Narrower conditions

Granulomatosis with Polyangiitis (12)  ·  Microscopic Polyangiitis (10)  ·  Churg-Strauss Syndrome (6)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (5)  ·  Behcet Syndrome (5)  ·  Giant Cell Arteritis (5)  ·  Polyarteritis Nodosa (5)  ·  Takayasu Arteritis (5)  ·  IgA Vasculitis (4)  ·  Vasculitis (4)  ·  Vasculitis, Central Nervous System (4)  ·  Systemic Vasculitis (3)  ·  Cryoglobulinemia, Familial Mixed (2)  ·  Cardiovascular Diseases (1)  ·  Lung Diseases (1)

Broader conditions

Autoimmune Diseases (12)  ·  Immune System Diseases (12)  ·  Skin Diseases (12)  ·  Skin Diseases, Vascular (12)  ·  Skin and Connective Tissue Diseases (12)  ·  Cardiovascular Diseases (11)  ·  Lung Diseases (11)  ·  Lung Diseases, Interstitial (11)  ·  Respiratory Tract Diseases (11)  ·  Vascular Diseases (11)  ·  Brain Diseases (10)  ·  Central Nervous System Diseases (10)  ·  Cerebral Small Vessel Diseases (10)  ·  Cerebrovascular Disorders (10)  ·  Nervous System Diseases (10)

Interventions

Rituximab (3)  ·  Azathioprine (2)  ·  Glucocorticoids (2)  ·  Hydroxychloroquine (1)  ·  Prednisolone (1)  ·  Prednisone (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)

Sponsors

University of South Florida (5)  ·  University of Pennsylvania (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Chiba University (1)  ·  Guy's and St Thomas' NHS Foundation Trust (1)  ·  University of Oxford (1)

Countries

United States (8)  ·  United Kingdom (3)  ·  Japan (2)  ·  Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Ireland (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Sweden (1)

Top investigators

Peter A. Merkel, MD, MPH (4)  ·  Amanda M. Terry, MA (2)  ·  Peter A Merkel, MD, MPH (2)  ·  Peter C. Grayson, MD (2)  ·  Antoine Sreih, MD (1)  ·  Christian Pagnoux, MD, MPH, MSc (1)  ·  David D'Cruz (1)  ·  David Jayne (1)  ·  Hiroshi Nakajima, M.D., Ph.D (1)  ·  Janice Mooney, M.Sc. (1)  ·  Jeffrey P Krischer, PhD (1)  ·  Jennifer L. Harris, MSPH, CCRP (1)  ·  Kathleen McKinnon, DO (1)  ·  Lianna Fraenkel, MD, MPH (1)  ·  Lillian Barra, MD, PhD (1)

Results publications

PMID 25372085, PMID 27049404, PMID 28246067, PMID 28270229, PMID 29247107, PMID 29724729, PMID 33164993, PMID 34061144, PMID 36958796, PMID 37024906, PMID 37734880, PMID 37903568, PMID 39425055

NIH funding

2018 (1), R01HL115041 (1)